Dr. Naomi Sacks, HEORStrategies Vice President, is a co-author of a study just published in the journal Obesity Science and Practice. Using national survey data from 2016-2018, Dr. Sacks and co-authors examined clinical, economic, and health-related quality of life outcomes associated with overweight and obesity. They found that increasing overweight and obesity are significantly associated with increasing numbers of obesity-related comorbidities, poorer health-related quality of life, decreased mobility and productivity, and greater levels of disability. Among national survey respondents with obesity, very few reported using prescription anti-obesity medication, despite reporting multiple weight loss attempts that did not result in clinically meaningful weight loss. The authors suggest that better use of existing evidence-based obesity treatments may achieve more clinically meaningful weight reduction, and improve health and economic outcomes in individuals with overweight and obesity.
You can see this important study at: Clinical, economic, and health‐related quality of life outcomes in patients with overweight or obesity in the United States: 2016–2018.